{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:01:06Z","timestamp":1792404066104,"version":"4.4.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1001\/jamacardio.2020.2614","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T11:54:19Z","timestamp":1594814059000},"page":"1113","source":"Crossref","is-referenced-by-count":25,"title":["Association of Natriuretic Peptide Levels After Transcatheter Aortic Valve Replacement With Subsequent Clinical Outcomes"],"prefix":"10.1001","volume":"5","author":[{"given":"Jared M.","family":"O\u2019Leary","sequence":"first","affiliation":[{"name":"Structural Heart and Valve Center, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Cardiovascular Medicine Division, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Annick","family":"Clavel","sequence":"additional","affiliation":[{"name":"Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shmuel","family":"Chen","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation, New York, New York"},{"name":"Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashish","family":"Goel","sequence":"additional","affiliation":[{"name":"Structural Heart and Valve Center, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Cardiovascular Medicine Division, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammy","family":"Elmariah","sequence":"additional","affiliation":[{"name":"Interventional Cardiology and Structural Heart Disease, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Crowley","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Alu","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation, New York, New York"},{"name":"Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod H.","family":"Thourani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Marcus Heart and Vascular Center, Piedmont Heart Institute, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Leon","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation, New York, New York"},{"name":"Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Pibarot","sequence":"additional","affiliation":[{"name":"Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Lindman","sequence":"additional","affiliation":[{"name":"Structural Heart and Valve Center, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Cardiovascular Medicine Division, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"21","key":"hoi200044r1","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.jacc.2010.05.049","article-title":"Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.","volume":"56","author":"Smith","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hoi200044r2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1001\/archinte.166.3.315","article-title":"Utility of amino-terminal pro\u2013brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.","volume":"166","author":"Januzzi","year":"2006","journal-title":"Arch Intern Med"},{"issue":"9","key":"hoi200044r3","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1161\/01.CIR.0000054164.99881.00","article-title":"Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).","volume":"107","author":"Anand","year":"2003","journal-title":"Circulation"},{"issue":"8853","key":"hoi200044r4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/0140-6736(93)93125-K","article-title":"Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction.","volume":"341","author":"Lerman","year":"1993","journal-title":"Lancet"},{"issue":"1","key":"hoi200044r5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/01.CIR.90.1.195","article-title":"Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.","volume":"90","author":"Yasue","year":"1994","journal-title":"Circulation"},{"issue":"19","key":"hoi200044r6","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1161\/01.CIR.0000126825.50903.18","article-title":"Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.","volume":"109","author":"Bergler-Klein","year":"2004","journal-title":"Circulation"},{"issue":"19","key":"hoi200044r7","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.jacc.2014.02.581","article-title":"B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival.","volume":"63","author":"Clavel","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"hoi200044r8","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/heartjnl-2015-307742","article-title":"Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement.","volume":"101","author":"Lindman","year":"2015","journal-title":"Heart"},{"issue":"1","key":"hoi200044r9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/CIRCULATIONAHA.108.808857","article-title":"Risk score for predicting outcome in patients with asymptomatic aortic stenosis.","volume":"120","author":"Monin","year":"2009","journal-title":"Circulation"},{"issue":"2, pt 1","key":"hoi200044r10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jcmg.2019.01.036","article-title":"Management of asymptomatic severe aortic stenosis: evolving concepts in timing of valve replacement.","volume":"13","author":"Lindman","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"17","key":"hoi200044r11","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients.","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"issue":"14","key":"hoi200044r12","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.jcin.2015.08.017","article-title":"A randomized evaluation of the SAPIEN XT transcatheter heart valve system in patients with aortic stenosis who are not candidates for surgery.","volume":"8","author":"Webb","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"10034","key":"hoi200044r13","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/S0140-6736(16)30073-3","article-title":"Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis.","volume":"387","author":"Thourani","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"hoi200044r14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/CIRCULATIONAHA.116.022797","article-title":"One-year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high-risk and inoperable patients with severe aortic stenosis.","volume":"134","author":"Herrmann","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"hoi200044r15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.echo.2013.01.013","article-title":"Implementation of echocardiography core laboratory best practices: a case study of the PARTNER I trial.","volume":"26","author":"Douglas","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"hoi200044r16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"issue":"15","key":"hoi200044r17","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.","volume":"60","author":"Kappetein","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"hoi200044r18","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jcin.2014.02.011","article-title":"Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations.","volume":"7","author":"Lindman","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"hoi200044r19","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jacc.2012.03.075","article-title":"Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial (cohort A).","volume":"60","author":"Reynolds","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hoi200044r20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/CIRCHEARTFAILURE.112.970053","article-title":"Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis.","volume":"6","author":"Arnold","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"21","key":"hoi200044r21","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/j.jcin.2018.07.039","article-title":"Multimarker approach to identify patients with higher mortality and rehospitalization rate after surgical aortic valve replacement for aortic stenosis.","volume":"11","author":"Lindman","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"hoi200044r22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1214\/ss\/1038425655","article-title":"Flexible smoothing with B-splines and penalties.","volume":"11","author":"Eilers","year":"1996","journal-title":"Stat Sci"},{"issue":"9","key":"hoi200044r23","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jacc.2019.06.055","article-title":"Natriuretic peptide response and outcomes in chronic heart failure with reduced ejection fraction.","volume":"74","author":"Januzzi","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"hoi200044r24","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jacc.2019.01.018","article-title":"B-type natriuretic peptide during treatment with sacubitril\/valsartan: the PARADIGM-HF trial.","volume":"73","author":"Myhre","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"hoi200044r25","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1016\/j.jacc.2016.09.931","article-title":"Prognostic implications of changes in N-terminal pro-B-type natriuretic peptide in patients with heart failure.","volume":"68","author":"Zile","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"hoi200044r26","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1001\/jamacardio.2016.1132","article-title":"Association of abnormal postoperative left ventricular global longitudinal strain with outcomes in severe aortic stenosis following aortic valve replacement.","volume":"1","author":"Kafa","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"11","key":"hoi200044r27","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.jcmg.2016.10.007","article-title":"Myocardial fibrosis and cardiac decompensation in aortic stenosis.","volume":"10","author":"Chin","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"hoi200044r28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1161\/CIRCULATIONAHA.108.847772","article-title":"Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis.","volume":"120","author":"Weidemann","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"hoi200044r29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jacc.2014.10.067","article-title":"Systemic vascular load in calcific degenerative aortic valve stenosis: insight from percutaneous valve replacement.","volume":"65","author":"Yotti","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hoi200044r30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jchf.2018.10.014","article-title":"NT-proBNP goal achievement is associated with significant reverse remodeling and improved clinical outcomes in HFrEF.","volume":"7","author":"Daubert","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"11","key":"hoi200044r31","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/jama.2019.12821","article-title":"Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction.","volume":"322","author":"Januzzi","year":"2019","journal-title":"JAMA"},{"issue":"17","key":"hoi200044r32","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.jacc.2016.07.762","article-title":"Prediction of poor outcome after transcatheter aortic valve replacement.","volume":"68","author":"Arnold","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"hoi200044r33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jcin.2014.01.167","article-title":"Futility, benefit, and transcatheter aortic valve replacement.","volume":"7","author":"Lindman","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"hoi200044r34","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.jacc.2018.12.049","article-title":"Hospital resource utilization before and after transcatheter aortic valve replacement: the STS\/ACC TVT registry.","volume":"73","author":"Vemulapalli","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hoi200044r35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004472","article-title":"Thirty-day readmissions after transcatheter aortic valve replacement in the United States: insights from the Nationwide Readmissions Database.","volume":"10","author":"Kolte","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"hoi200044r36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.amjmed.2014.10.054","article-title":"Left ventricular hypertrophy in valvular aortic stenosis: mechanisms and clinical implications.","volume":"128","author":"Rader","year":"2015","journal-title":"Am J Med"},{"issue":"21","key":"hoi200044r37","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1001\/jama.2018.18077","article-title":"Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter aortic valve replacement.","volume":"320","author":"Inohara","year":"2018","journal-title":"JAMA"},{"issue":"8","key":"hoi200044r38","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/heartjnl-2017-311738","article-title":"Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation.","volume":"104","author":"Ochiai","year":"2018","journal-title":"Heart"},{"issue":"2","key":"hoi200044r39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020255","article-title":"Impact of renin-angiotensin system inhibitors on clinical outcomes and ventricular remodelling after transcatheter aortic valve implantation: rationale and design of the RASTAVI randomised multicentre study.","volume":"8","author":"Amat-Santos","year":"2018","journal-title":"BMJ Open"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2768443\/jamacardiology_oleary_2020_oi_200044_1602688147.2851.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T11:01:40Z","timestamp":1603278100000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2768443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2020.2614","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738335861.793576819","asserted-by":"object"}]},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}